Key Market Segments in the Protein A Resins Market Snapshot 2023 to 2033
The global protein a resins market is on a remarkable growth trajectory, with its valuation expected to nearly double from USD 677.84 million in 2023 to approximately USD 1,477.01 million by 2033. This represents a robust compound annual growth rate (CAGR) of 8.1% over the forecast period.
This
exceptional growth is being driven by the escalating demand for protein purification processes across
various sectors, including biotechnology, pharmaceuticals, and diagnostics.
Protein A resins, recognized for their efficacy in monoclonal antibody (mAb)
purification, are at the heart of advancements in therapeutic antibody
production, fueling their adoption worldwide.
Key
Drivers of Market Growth:
- Biopharmaceutical Production Surge: Increasing
production of biopharmaceuticals, particularly monoclonal antibodies, is
driving the need for advanced purification techniques, with protein A
resins emerging as a critical solution.
- Technological Advancements: Ongoing
innovations in resin technology and manufacturing processes are enhancing
the efficiency and effectiveness of protein purification, accelerating
market growth.
- Expanding Research Initiatives: The growing
emphasis on research and development in biotechnology and life sciences is
generating demand for high-quality purification solutions.
- Regulatory Support: Favorable
regulatory frameworks and government initiatives across the UK and Europe
are creating a supportive environment for biopharmaceutical manufacturing,
promoting market expansion.
"With
the UK poised to capture a significant share of the European protein A resins
market, we anticipate notable investments and technological advancements in
this sector," commented a Future Market Insights. "Our projections
highlight the essential role of protein A resins in enabling biopharmaceutical
innovation and enhancing therapeutic outcomes."
As the
protein A resins market evolves, FMI encourages manufacturers, researchers, and
investors to leverage the vast opportunities within this field, positioning
themselves competitively to benefit from the forecasted growth trajectory.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends! https://www.globenewswire.com/en/news-release/2024/01/09/2806396/0/en/Global-Protein-A-Resins-Industry-is-Projected-to-Reach-a-Staggering-US-1-477-01-Million-by-2033-driven-by-the-fervor-for-Monoclonal-Antibodies-as-per-Future-Market-Insights-Inc.html
Top Highlights from the FMI’s Analysis of the Protein A Resins
Market:
- The United States protein A resins
industry is expected to acquire more than 93.5% value share of the North
America market.
- Within Europe, the United Kingdom protein
A resins industry is expected to take 24.1% of the pie in 2033.
- The China market is anticipated to
enlarge at a CAGR of 9.8% over the upcoming years.
- High demand for natural protein A resin
is expected to yield a large market share in 2023.
- Under the matrix category, the
agarose-composed matrix of protein A resins is expected to record 85.8% of
the market share in 2023.
- The antibody purification segment is
projected to gain 74.8% of the global market.
- The biopharmaceutical manufacturers
segment is expected to emerge as the chief end user of the market, gaining
as high as 79.2% of the market in 2023.
Key Players in the Market are:
- GE Healthcare
- Thermo Fisher
Scientific
- Kaneka
Corporation,
- JNC
Corporation
- Purolite Life
Sciences
- Bio-Rad
Laboratories, Inc.
- JSR
Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh
Bioscience, Merck Group (Merck Millipore)
- Novasep
Holdings SAS, Agilent Technologies, Inc.
- GenScript,
Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio,
PerkinElmer, Inc.
- Suzhou
Nanomicro Technology Co., Ltd
Protein A Resins Market by Category:
Product:
- Natural
Protein A Resin
- Recombinant
Protein A Resin
Matrix:
- Agarose-based
Matrix
- Glass or
Silica-based Matrix
- Organic
Polymer-based Matrix
Application:
- Immunoprecipitation
- Antibody
Purification
End User:
- Biopharmaceutical
Manufacturers
- Clinical
Research Laboratories
- Academic
Institutes
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle
East and Africa (MEA)
About
Future Market Insights (FMI)
Future
Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a
member of the Greater New York Chamber of Commerce) offers profound insights
into the driving factors that are boosting demand in the market. FMI stands as
the leading global provider of market intelligence, advisory services,
consulting, and events for the Packaging, Food and Beverage, Consumer Technology,
Healthcare, Industrial, and Chemicals markets. With a vast team of over 400
analysts worldwide, FMI provides global, regional, and local expertise on
diverse domains and industry trends across more than 110 countries.
Contact
Us:
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Comments
Post a Comment